找回密码
 立即注册
首页 Financial China 查看内容
  • QQ空间

China greenlights two IPOs on sci-tech innovation board

2020-5-18 11:07

 

BEIJING, May 17 (Xinhua) -- China's securities regulator has given the nod to the registration of initial public offerings (IPOs) of two companies on the science and technology innovation board.

 

Beijing Bohui Science & Technology Co., Ltd., a Beijing-based information tech firm and Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., a Shanghai-based pharmaceutical company, will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, according to the China Securities Regulatory Commission.

 

It did not specify the total amount of funds to be raised.

 

The companies and their underwriters will respectively confirm the IPO dates and publish the prospectus following discussions with the stock exchange.

 

The STAR market, inaugurated in June last year and designed to support companies in the high-tech and strategic emerging sectors, eases the listing criteria but adopts higher requirements for information disclosure.

 

北京,5月17日(新华社)——中国证券监管机构已经批准两家公司在科技创新委员会进行首次公开募股(ipo)登记。


北京博汇科技有限公司和上海复旦张江生物制药有限公司,将在上海证券交易所科创板上市


声明没有具体说明将筹集的资金总额。


两家公司及其承销商将分别确认上市日期,并在与港交所讨论后公布招股说明书。


星港于去年6月启动,旨在支持高科技和战略性新兴行业的公司。星港放宽了上市标准,但对信息披露提出了更高的要求。

 

来自: xinhua